Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus

被引:32
作者
Warris, A [1 ]
Netea, MG
Wang, JE
Gaustad, P
Kullberg, BJ
Verweij, PE
Abrahamsen, TG
机构
[1] Aker Univ Hosp, Rikshosp, Dept Microbiol, Oslo, Norway
[2] Aker Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway
[3] Aker Univ Hosp, Rikshosp, Dept Paediat Res, Oslo, Norway
[4] Univ Med Ctr, Dept Pediat, Nijmegen, Netherlands
[5] Univ Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[6] Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands
[7] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
关键词
D O I
10.1080/00365540310013009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The release of tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and IL-10 upon stimulation with non-viable conidia and hyphal fragments from Aspergillus fumigatus was investigated in an ex vivo whole-blood model. In healthy volunteers, high numbers of conidia (between 10(6) and 3x10(8)/ml) induced a moderate release of TNF-alpha and IL-6. Hyphal fragments (2.5x10(5)/ml) were more potent in stimulating the release of these pro-inflammatory cytokines. Although some IL-10 release was observed upon stimulation with either conidia or hyphal fragments, it was not significantly different from that in unstimulated controls. In comparison, in whole blood obtained from 4 patients with chronic granulomatous disease (CGD), a high release of proinflammatory cytokines together with a significantly higher IL-10 release than in the healthy controls was seen after stimulation with A. fumigatus. In conclusion, A. fumigatus can trigger the release of pro-inflammatory cytokines in a human whole-blood system, which is likely to be central to the activation of antifungal defence mechanisms. In contrast, A. fumigatus stimulates a higher release of anti-inflammatory cytokines in CGD patients, which may suggest that a dysregulation between pro- and anti-inflammatory cytokines contributes to the increased susceptibility to invasive aspergillosis in this patient group.
引用
收藏
页码:482 / 487
页数:6
相关论文
共 30 条
  • [1] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [2] Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17
  • [3] ACTIVATION OF NEUTROPHILS BY RECOMBINANT INTERLEUKIN-6
    BORISH, L
    ROSENBAUM, R
    ALBURY, L
    CLARK, S
    [J]. CELLULAR IMMUNOLOGY, 1989, 121 (02) : 280 - 289
  • [4] Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis
    Cenci, E
    Mencacci, A
    d'Ostiani, CF
    Del Sero, G
    Mosci, P
    Montagnoli, C
    Bacci, A
    Romani, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) : 1750 - 1760
  • [5] Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis
    Cenci, E
    Mencacci, A
    Casagrande, A
    Mosci, P
    Bistoni, F
    Romani, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (05) : 610 - 617
  • [6] Cytokine- and T-helper-dependent immunity in murine aspergillosis
    Cenci, E
    Mencacci, A
    d'Ostiani, CF
    Montagnoli, C
    Bacci, A
    Del Sero, G
    Perito, S
    Bistoni, F
    Romani, L
    [J]. RESEARCH IN IMMUNOLOGY, 1998, 149 (4-5): : 445 - 454
  • [7] Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis
    Clemons, KV
    Grunig, G
    Sobel, RA
    Mirels, LF
    Rennick, DM
    Stevens, DA
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (02) : 186 - 191
  • [8] DE WMR, 1991, J EXP MED, V174, P1209
  • [9] Invasive aspergillosis
    Denning, DW
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 781 - 803
  • [10] DIAMOND R, 1978, AM J PATHOL, V1, P313